Ying-qi Song
Haikou, 570228, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Chemical and genetic molecular glues to degrade CoREST corepressors.
Journal: Acta pharmaceutica Sinica. B
Published: April 27, 2025
[18F]QTFT, a nicotinate-based radiotracer targeting P2Y12 with satisfactory blood‒brain barrier (BBB) permeability.
Journal: Acta pharmaceutica Sinica. B
Published: February 07, 2025
A Bioactive Benzimidazole-Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED-EZH2 Interaction.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: July 11, 2024
RMC-7977, a highly selective inhibitor of the active RAS-GTP to treat pancreatic cancer.
Journal: Acta pharmaceutica Sinica. B
Published: June 10, 2024
A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability.
Journal: European journal of medicinal chemistry
Published: September 16, 2023
A robust luminescent assay for screening alkyladenine DNA glycosylase inhibitors to overcome DNA repair and temozolomide drug resistance.
Journal: Journal of pharmaceutical analysis
Published: January 06, 2023
The role and prospect of lysine-specific demethylases in cancer chemoresistance.
Journal: Medicinal research reviews
Published: June 23, 2022
An optimized BRD4 inhibitor effectively eliminates NF-κB-driven triple-negative breast cancer cells.
An optimized BRD4 inhibitor effectively eliminates NF-κB-driven triple-negative breast cancer cells.
Journal: Bioorganic chemistry
Published: May 23, 2021
Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer.
Journal: Frontiers in cell and developmental biology
Published: February 08, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026